Clusterland Sweden — Digital Health & MedTech Consultancy

Micael Gustafsson

Founder · Clusterland Sweden

The person behind the work

Two decades at the intersection of medicine, technology, and markets

I'm Micael Gustafsson — MBA from Lund University, and for the past 15+ years I've worked at the point where digital health products either succeed commercially or don't. I've been the person who builds the structure that makes them succeed.

My background spans acting CEO roles, EU-level advisory positions, and hands-on commercial director mandates for MedTech companies — always with skin in the game. I've steered companies through MDR certification, built distributor networks from scratch, written investor memoranda that secured funding, and sat at the table with clinicians, regulators, and procurement leads across Europe.

I'm an EU consultant on digitalisation, a former cluster CEO across the Öresund region, and I've supported EU Commission initiatives including DIGISTART and EMMIA. I don't do generic consulting. I do embedded, accountable commercial work in Digital Health and MedTech.

Education

MBA, Lund University

Base

Limhamn, Sweden

EU roles

DIGISTART · EMMIA · H2020

Specialisation

MedTech · Digital Health · Life Science

Selected engagements

Projects that shaped the work

A selection of the companies and programmes Clusterland Sweden has been directly involved in — from acting CEO mandates to EU-funded innovation projects. MedTech and Digital Health engagements are highlighted first.

Digital Health · DTx

Learning to Sleep

Board & Commercial Advisory

A CE-marked, Läkemedelsverket-approved digital treatment for insomnia based on cognitive behavioural therapy (CBT). Delivered entirely via app with psychologist support — 5-week programme, 6 psychologist sessions. Clusterland Sweden supported commercial strategy and market positioning for this pioneering Swedish DTx company.

94% Patients report measurable sleep improvement

2 000+ Patients treated in Sweden

CE Certified & Läkemedelsverket approved

MedTech · Remote Patient Monitoring

Cross Technology Solutions — LifePod

Investor Memorandum & Commercial Strategy

LifePod is one of Europe's most capable Remote Patient Monitoring (RPM) platforms — CE IIa certified and ISO 13485 compliant. Winner of the eHealth Award at Vitalis 2019 and Connected Health Company of the Year 2017. Clusterland Sweden supported the investor memorandum and strategic positioning for a long-term partnership or acquisition process.

844k Patient interactions per year

60% Reduced COPD readmission risk

50 Connected healthcare providers

MedTech · Acting CEO

Starfish of Sweden

Acting CEO · 1.5 years

Starfish of Sweden has developed a patented, scientifically validated platform to prevent pressure ulcers — one of healthcare's most costly and preventable conditions. The technology limits body-surface contact to just 20%, controlling temperature and moisture to maintain skin integrity. Validated with Lund University (LTH). As acting CEO, I led commercial strategy, investor relations, and the partnership programme — including a landmark collaboration with Forenede Care and a joint venture in the automotive sector.

20% Body contact surface — core patented tech

LTH Clinically validated with Lund University

$500B Global cost of pressure ulcers annually

EU H2020

DIGISTART

Partner · Consortium Member

EU Horizon 2020-funded programme supporting digital startup ecosystems. Clusterland Sweden connected Malmö's startup scene to Lisbon, running acceleration programmes in sync with the Portuguese ecosystem and linking Swedish founders to international opportunities.

EU CIP · Mobile & Mobility

EMMIA — European Mobile & Mobility Industries Alliance

Core Contractor · Cluster 55° / Öresund

European Commission-backed alliance of 31 organisations from 14 countries developing mobile service policy for Europe. Clusterland Sweden (as Cluster 55°) was a core contractor representing the Öresund region, contributing to the Policy Learning Platform and large-scale demonstrators.

Vinnova · Social Innovation

Escalate

Programme Lead

Vinnova-funded accelerator for foreign-born entrepreneurs in Sweden, developed in collaboration with Malmö City, Region Skåne, and MINC Incubator. Built methodology for rapid company acceleration that increased revenues multi-fold within a 12-week programme cycle.

What I bring

End-to-end digital health expertise

Market Entry Strategy

From regulatory scoping to distributor onboarding — I design and execute go-to-market plans built around clinical, regulatory, and commercial realities.

EU launchUS entryDistributor network

Regulatory Navigation

Experienced in MDR Class IIa CE certification and FDA 510(k) pathways — including clinical evidence strategies, PICO frameworks, and regulatory submissions.

MDR Class IIaFDA 510(k)Clinical evidence

Commercial Leadership

Acting as interim or fractional Commercial Director for MedTech companies — owning revenue targets, channel strategy, and distribution partnerships across markets.

Interim CEO/CDSales structureKPI frameworks

Clinical Communication

Translating clinical evidence for medically trained audiences — KOL engagement, rep training programmes, and evidence-based sales enablement tools.

KOL strategyRep trainingPICO evidence

Digital Health Systems

Deep experience in ICT-for-health, smart city health infrastructure, and the EU policy environment that shapes adoption across European healthcare systems.

eHealthHealth ITEU policy

Investor & Partner Relations

Building investor narratives, TAM–SAM–SOM models, and partnership frameworks for MedTech scale-ups seeking growth capital or strategic alliances.

Investor decksTAM analysisPartnerships

Featured engagement

AiroQur — respiratory MedTech, commercialised

Commercial Director · Ongoing

Taking a medical-grade respiratory device from R&D to regulated market

AiroQur, developed by Airofit in Denmark, is a medical-grade respiratory muscle training device for patients with COPD, asthma, and other chronic respiratory conditions. As Commercial Director, I lead market entry across Europe and the US — spanning regulatory strategy, distributor partnerships, and clinical sales enablement.

Working alongside a Linde distribution agreement in Portugal, I built onboarding content for medically trained reps, developed the PICO evidence framework for clinical conversations, and am steering the FDA 510(k) process for US entry.

IIaMDR classification — CE certification in progress

22Clinical sales reps onboarded, Portugal launch

510(k)FDA pathway — US market entry active

EU + USDual market commercial strategy

AiroQur

by Airofit · Medical-grade RMT device

Regulatory strategy — MDR Class IIa CE pathway and FDA 510(k) preparation for US market entry

Distribution buildout — Linde partnership for European distribution; rep onboarding programme for Portugal launch

Clinical evidence framework — PICO-based summary aligning RMT literature with AiroQur's clinical positioning

Sales enablement — Onboarding video content and clinical messaging for medically trained representatives

Micael Gustafsson · Commercial Director Clusterland Sweden for Airofit A/S, Denmark

How I work

Embedded, accountable, results-driven

Understand the clinical and commercial context

Every device, every market, every payer is different. I start with deep listening before recommending anything.

Map the regulatory pathway

MDR, FDA, or both — I identify the right route, the realistic timeline, and the clinical evidence needed to get there.

Build the commercial structure

Pricing, distribution, sales training, KPI frameworks — all built to match how healthcare procurement actually works.

Execute and stay accountable

I don't hand over a report and disappear. I stay in the engine room until the results materialise.

"I never take an assignment I don't think I can deliver on — and I never charge for a conversation. Let's talk about your product."

Micael Gustafsson · Clusterland Sweden

Where clinical expertise meets commercial strategy